For 30 years, companies in healthcare and other industries have relied on agency guidance immunizing certain kinds of information exchanges with competitors. How does DOJ’s recent withdrawal of these safe harbors change the landscape? Leslie Overton, former DOJ official and currently a partner at Axinn, Veltrop & Harkrider, joins Sergei Zaslavsky and Jaclyn Phillips to discuss DOJ’s policy change. Listen to this episode to learn more about the antitrust agencies’ approach to information exchanges and what the withdrawal of prior policy statements means for practitioners and in-house counsel.
Leslie Overton, Axinn, Veltrop & Harkrider
DOJ announcement of withdrawal of healthcare policy statements
Principal Deputy Assistant Attorney General Doha Mekki’s speech regarding withdrawal of policy statements
Sergei Zaslavsky, O’Melveny & Myers and Jaclyn Phillips, White & Case